These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3799819)

  • 1. Aproliferin--a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiation.
    Wier ML; Scott RE
    Am J Pathol; 1986 Dec; 125(3):546-54. PubMed ID: 3799819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aproliferin: a modulator of proliferative potential.
    Wier ML; Scott RE
    Biofactors; 1988 Jul; 1(2):129-31. PubMed ID: 3076440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the terminal event in cellular differentiation: biological mechanisms of the loss of proliferative potential.
    Wier ML; Scott RE
    J Cell Biol; 1986 May; 102(5):1955-64. PubMed ID: 2422182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiation.
    Filipak M; Sparks RL; Tzen CY; Scott RE
    J Cell Physiol; 1988 Nov; 137(2):367-73. PubMed ID: 3192620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.
    Sparks RL; Seibel-Ross EI; Wier ML; Scott RE
    Cancer Res; 1986 Oct; 46(10):5312-9. PubMed ID: 3756880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypeptide changes associated with loss of proliferative potential during the terminal event in differentiation.
    Wier ML; Scott RE
    J Cell Biochem; 1987 Feb; 33(2):137-50. PubMed ID: 2437134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific expression of proteins and phosphoproteins in 3T3 T mesenchymal stem cells at distinct growth arrest and differentiation states.
    Sparks RL; Zschunke MA; Seibel-Ross EI; Tracy R; Zalitis JG; Boman BM; Hoerl BJ; Scott RE
    Cell Tissue Kinet; 1990 Mar; 23(2):71-87. PubMed ID: 2317836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated control of proliferation and differentiation of mesenchymal stem cells.
    Filipak M; Estervig DN; Tzen CY; Minoo P; Hoerl BJ; Maercklein PB; Zschunke MA; Edens M; Scott RE
    Environ Health Perspect; 1989 Mar; 80():117-25. PubMed ID: 2647473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three distinct effects of SV40 T-antigen gene transfection on cellular differentiation.
    Estervig DN; Minoo P; Tzen CY; Scott RE
    J Cell Physiol; 1990 Mar; 142(3):552-8. PubMed ID: 2312615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preadipocyte stimulating factor in rat serum: evidence for a discrete 63 kDa protein that promotes cell differentiation of rat preadipocytes in primary cultures.
    Li ZH; Lu ZD; Kirkland JL; Gregerman RI
    J Cell Physiol; 1989 Dec; 141(3):543-57. PubMed ID: 2687298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation.
    Scott RE; Hoerl BJ; Wille JJ; Florine DL; Krawisz BR; Yun K
    J Cell Biol; 1982 Aug; 94(2):400-5. PubMed ID: 6809770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective control of terminal differentiation and its role in carcinogenesis in the 3T3 T proadipocyte stem cell line.
    Wier ML; Scott RE
    Cancer Res; 1985 Jul; 45(7):3339-46. PubMed ID: 4005857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle models for the aberrant coupling of growth arrest and differentiation in hyperplasia, metaplasia, and neoplasia.
    Scott RE; Florine DL
    Am J Pathol; 1982 Jun; 107(3):342-8. PubMed ID: 7081388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the adipose conversion of 3T3 cells by acidified serum.
    Kuri-Harcuch W; Green H
    J Cell Physiol; 1981 Sep; 108(3):455-60. PubMed ID: 7287829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cells.
    Sparks RL; Strauss EE; Zygmunt AI; Phelan TE
    J Cell Physiol; 1991 Jan; 146(1):101-9. PubMed ID: 1990013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.
    Jiang H; Lin J; Young SM; Goldstein NI; Waxman S; Davila V; Chellappan SP; Fisher PB
    Oncogene; 1995 Sep; 11(6):1179-89. PubMed ID: 7566979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of differentiation control in transformed 3T3 T proadipocytes.
    Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
    Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of the intracellular Ca(2+)-ATPase in cultured mouse keratinocytes reveal components of terminal differentiation that are regulated by distinct intracellular Ca2+ compartments.
    Li L; Tucker RW; Hennings H; Yuspa SH
    Cell Growth Differ; 1995 Sep; 6(9):1171-84. PubMed ID: 8519694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to neoplastic transformation induced by nonterminal differentiation.
    Estervig DN; Maercklein PB; Scott RE
    Cancer Res; 1989 Feb; 49(4):1008-13. PubMed ID: 2912546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.